Takeda Presents RealWorld Vedolizumab Data in Ulcerative Colitis and Crohn's Disease at 2016 American College of Gastroenterology ACG Annual Scientific Meeting

DEERFIELD Ill. Oct. 17 2016 PRNewswire Today Takeda Pharmaceuticals U.S.A. Inc. "Takeda" announced data highlighting the effectiveness and safety profile of vedolizumab for the treatment of adults with moderately to severely active ulcerative co...